XNYS · PHARMACEUTICAL PREPARATIONS · PHARMACEUTICAL PREPARATIONS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Abbvie (ABBV) had 1 Form 144 pre-sale notice filed on 2026-05-26. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 5/8/2026 | Hart Brett J | — | GRANT | 1,118 | — | — |
| 5/8/2026 | FALK THOMAS J | — | GRANT | 1,118 | — | — |
| 5/8/2026 | WADDELL FREDERICK H | — | GRANT | 1,118 | — | — |
| 5/8/2026 | Roberts Rebecca B | — | GRANT | 1,118 | — | — |
| 5/8/2026 | RAPP EDWARD J | — | GRANT | 1,118 | — | — |
| 5/8/2026 | Quaggin Susan E | — | GRANT | 1,118 | — | — |
| 5/8/2026 | MEYER MELODY B | — | GRANT | 1,118 | — | — |
| 5/8/2026 | FREYMAN THOMAS C | — | GRANT | 1,118 | — | — |
| 5/8/2026 | Davis Jennifer L. | — | GRANT | 1,118 | — | — |
| 5/8/2026 | BURNSIDE WILLIAM H.L. | — | GRANT | 1,118 | — | — |
| 3/31/2026 | Quaggin Susan E | — | GRANT | 71 | $217 | $15,442 |
| 3/31/2026 | RAPP EDWARD J | — | GRANT | 155 | $217 | $33,711 |
| 3/31/2026 | Alpern Robert J | — | GRANT | 35 | $217 | $7,612 |
| 3/4/2026 | Purdue David Ryan | SVP, Controller | SELL | -5,230 | $234 | $1,221,519 |
| 3/2/2026 | Siatis Perry C | EVP, GC AND SECRETARY | SELL | -5,777 | $234 | $1,348,987 |
| 3/2/2026 | Siatis Perry C | EVP, GC AND SECRETARY | SELL | -10,291 | $235 | $2,414,886 |
| 3/2/2026 | Siatis Perry C | EVP, GC AND SECRETARY | SELL | -2,600 | $235 | $611,676 |
| 2/27/2026 | Purdue David Ryan | SVP, Controller | TAX_WITHHOLD | -2,108 | $232 | $489,225 |
| 2/27/2026 | Crum Demetris D | EVP, CHIEF HR OFFICER | TAX_WITHHOLD | -1,594 | $232 | $369,936 |
| 2/27/2026 | Thakkar Roopal | EVP, R&D and CSO | TAX_WITHHOLD | -8,037 | $232 | $1,865,227 |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 5/26/2026 | ROBERT J ALPERN | — | 13,000 | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 180,779,699 | $41,306,353,424 | — | 1/29/2026 |
| BlackRock | 136,431,510 | $23,400,732,597 | — | 8/13/2024 |
| State Street | 80,940,931 | $18,494,193,324 | — | 2/13/2026 |
| JP Morgan Chase | 53,175,823 | $12,150,144,455 | — | 2/11/2026 |
| Fidelity (FMR) | 22,609,389 | $5,166,019,290 | — | 2/17/2026 |
| Citadel Advisors | 4,199,951 | $959,646,804 | — | 2/17/2026 |
| AQR Capital | 1,150,746 | $262,933,724 | — | 2/17/2026 |
| DE Shaw | 1,149,336 | $262,611,783 | — | 2/17/2026 |
| Millennium Management | 1,040,193 | $237,673,699 | — | 2/17/2026 |
| Two Sigma | 167,812 | $38,343,364 | — | 2/17/2026 |
| Point72 | 105,400 | $24,082,846 | — | 2/17/2026 |
| Bridgewater Associates | 14,209 | $3,246,614 | — | 2/13/2026 |